Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide. In: IARC CancerBase, vol. 11. Lyon, France: International Agency for Research on Cancer; 2012.
Google Scholar
Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999;318(7188):904–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy.[comment]. Am J Epidemiol. 1995;141(7):680–9.
CAS
PubMed
Google Scholar
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselbad V, Hickey JD. Accuracy of the Papanicoloau test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810–9.
Article
CAS
PubMed
Google Scholar
Franco EL, Mahmud SM, Tota J, Ferenczy A, Coutlée F. The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change. Arch Med Res. 2009;40(6):478–85.
Article
PubMed
Google Scholar
Bosch FX, Munoz N. The viral etiology of cervical cancer. Virus Res. 2002;89(2):183–90.
Article
CAS
PubMed
Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
Article
CAS
PubMed
Google Scholar
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.
Article
PubMed
Google Scholar
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, Schiffman M, et al. Human papillomavirus and cervical cancer. [Review] [172 refs]. Lancet. 2007;370(9590):890–907.
Article
CAS
PubMed
Google Scholar
Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomark Prev. 2000;9(9):945–51.
CAS
Google Scholar
Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study.[see comment]. Lancet. 2003;362(9399):1871–6.
Article
CAS
PubMed
Google Scholar
Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754.
Article
PubMed
PubMed Central
Google Scholar
Franco EL. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr. 2003;31:89–96.
Article
PubMed
Google Scholar
Franco EL, Ferenczy A, Franco EL, Ferenczy A. Is HPV testing with cytological triage a more logical approach in cervical cancer screening?[comment]. Lancet Oncol. 2006;7(7):527–9.
Article
PubMed
Google Scholar
Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524–32.
Article
PubMed
Google Scholar
Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.[see comment]. N Engl J Med. 2007;357(16):1579–88.
Article
CAS
PubMed
Google Scholar
Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189–97.
Article
PubMed
Google Scholar
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249–57.
Article
CAS
PubMed
Google Scholar
Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst. 2009;101(23):1612–23.
Article
CAS
PubMed
Google Scholar
Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ. 2010;340:c1804.
Article
PubMed
PubMed Central
Google Scholar
Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler CM. EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer. 2009;125(10):2246–55.
Article
CAS
PubMed
Google Scholar
Ogilvie GS, Smith LW, van Niekerk DJ, Khurshed F, Krajden M, Saraiya M, et al. Women’s intentions to receive cervical cancer screening with primary human papillomavirus testing. Int J Cancer. 2013;133(12):2934–43.
CAS
PubMed
PubMed Central
Google Scholar
McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer. 2003;88(1):42–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D, Flores B, et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health. 2009;14(6):607–24.
Article
PubMed
PubMed Central
Google Scholar
Anhang R, Wright Jr TC, Smock L, Goldie SJ. Women’s desired information about human papillomavirus. Cancer. 2004;100(2):315–20.
Article
PubMed
Google Scholar
Ogilvie GS, vanNiekerk D, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook DA, et al. A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer. 2010;10:111.
Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K, et al. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial - the HPV FOCAL Study. Br J Cancer. 2012;107(12):1917–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis. 1991;50:179–211.
Article
Google Scholar
Hankins M, French D, Horne R. Statistical Guidelines for Studies of the Theory of Reasoned Action and the Theory of Planned Behaviour. Psychol Health. 2000;15:151–61.
Article
Google Scholar
Hosmer DW, Lemeshow S, Sturdivant RX. Wiley Series in Probability and Statistics : Applied Logistic Regression (3rd Edition). New York: Wiley; 2013.
Book
Google Scholar
Murphy J, Kennedy EB, Dunn S, McLachlin M, Fung Kee Fung M, Gzik D, et al. HPV testing in Primary Cervical Screening: A Systematic Review and Meta-Analysis. J Obstet Gynaecol Can. 2012;34(5):443–52.
Article
PubMed
Google Scholar
Health Council of the Netherlands: Population screening for cervical cancer. The Hague: Health Council of the Netherlands, 2011 2011, Publication no. 2011/07.
Murphy J, Kennedy EB, Dunn S, McLachlin CM, Fung Kee FM, Gzik D, et al. Cervical screening: a guideline for clinical practice in Ontario. J Obstet Gynaecol Can. 2012;34(5):453–8.
Article
PubMed
Google Scholar
Moyer VA. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012;156(12):880–91.
Article
PubMed
Google Scholar
Australian Government Medical Services Advisory Committee: Renewal of the National Cervical Screening Program. In: MSAC 61st Meeting. Canberra: Australian Government Department of Health; 2014.
Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A: HPV testing with cytology triage for cervical cancer screening in routine practice. Am J Obstet Gynecol 2014, 210(5):474.e471-474.e477.
Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE. Patient Concerns About Human Papillomavirus Testing and 5-Year Intervals in Routine Cervical Cancer Screening. Obstet Gynecol. 2015;125(2):317–29.
Article
PubMed
PubMed Central
Google Scholar
Hawkins N, Benard V, Greek A, Roland K, Manninen D, Saraiya M. Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev Med. 2013;57(5):641–5.
Article
PubMed
PubMed Central
Google Scholar
Saraiya M, Berkowitz Z, Yabroff K, Wideroff L, Kobrin S, Benard V. Cervical cancer screening with both human papillomavirus and papanicolaou testing vs papanicolaou testing alone: What screening intervals are physicians recommending? Arch Intern Med. 2010;170(11):977–86.
Article
PubMed
Google Scholar
Meissner HI, Tiro JA, Yabroff KR, Haggstrom DA, Coughlin SS. Too Much of a Good Thing? Physician Practices and Patient Willingness for Less Frequent Pap Test Screening Intervals. Med Care. 2010;48(3):249–59.
Article
PubMed
Google Scholar
Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R. Patients’ anxiety and expectations: how they influence family physicians’ decisions to order cancer screening tests. Can Fam Physician. 2005;51(12):1658–9.
PubMed
Google Scholar
Perkins R, Anderson B, Gorin S, Schulkin J. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Am J Prev Med. 2013;45(2):175–81.
Article
PubMed
Google Scholar
O’Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O’Leary JJ, et al. ‘I don’t care whether it’s HPV or ABC, I just want to know if I have cancer’. Factors influencing women’s emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study. BJOG. 2014;121(11):1421–30.
Article
PubMed
Google Scholar